Conavi Medical Corp.
CNVIF
$0.27
$0.001.09%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.67% | -91.68% | -- | -- | 57.39% |
| Total Depreciation and Amortization | -6.09% | -0.60% | -- | -- | 38.88% |
| Total Amortization of Deferred Charges | -30.08% | -5.38% | -- | -- | -- |
| Total Other Non-Cash Items | -202.77% | 365.22% | -- | -- | -106.99% |
| Change in Net Operating Assets | 196.64% | 81.73% | -- | -- | -174.41% |
| Cash from Operations | 15.87% | 35.51% | -- | -- | -90.29% |
| Capital Expenditure | -168.75% | -86.05% | -- | -- | 82.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.71% | -- | -- | -- | 7,842.03% |
| Cash from Investing | -43.25% | -1,588.37% | -- | -- | 1,855.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -61.13% | 29.67% | -- | -- | -152.94% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.35% | -- | -- | -- |
| Cash from Financing | -31.98% | -102.03% | -- | -- | 180.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.59% | -153.35% | -- | -- | 446.14% |